c-Abl-p38α signaling plays an important role in MPTP-induced neuronal death

R Wu1,2, H Chen1,3, J Ma1,2

  • 1State Key Laboratory of Brain and Cognitive Sciences, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.

Insights

Oxidative stress contributes to Parkinson's disease (PD). Targeting the c-Abl and p38α signaling pathway may offer a new therapeutic strategy for PD by protecting neuronal cells.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Oxidative stress is a key factor in sporadic Parkinson's disease (PD) pathogenesis.
  • Neuronal cell death is a hallmark of PD, leading to motor deficits.

Purpose of the Study:

  • To investigate the role of c-Abl in oxidative stress-induced neuronal cell death in Parkinson's disease.
  • To identify downstream targets of c-Abl involved in PD pathology.

Main Methods:

  • Utilized a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP) induced mouse model of acute Parkinson's disease.
  • Employed conditional knockout of c-Abl in neurons and pharmacological inhibition with STI571.
  • Applied Stable Isotope Labeling with Amino acids in Cell culture (SILAC) combined with biochemical assays to identify protein interactions and modifications.

Main Results:

  • c-Abl kinase was activated in the MPTP-induced PD model.
  • Inhibition or knockout of c-Abl protected dopaminergic neurons and improved motor function in MPTP-treated mice.
  • Identified p38α as a critical substrate of c-Abl, with c-Abl-mediated phosphorylation essential for p38α dimerization.
  • Inhibition of p38α also ameliorated neuronal loss in the PD model.

Conclusions:

  • The c-Abl-p38α signaling pathway is implicated in oxidative stress-induced dopaminergic neuron death in Parkinson's disease.
  • Targeting the c-Abl-p38α axis presents a potential therapeutic strategy for Parkinson's disease.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...